India to Grenada: Ibrutinib Export Trade Route

The India to Grenada Ibrutinib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $28.5K USD. The route is dominated by MEDIGEN PHARMA, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $14.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 10.1%, placing it at rank #10 among India's top ibrutinib export destinations globally.

On the import side, key buyers of Indian ibrutinib in Grenada include INVOICE RAISED TO. INVOICE RAISED TO is the single largest importer with 2 shipments valued at $28.5K USD.

India's ibrutinib exports to Grenada are driven primarily by a handful of large-scale manufacturers. MEDIGEN PHARMA with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Grenada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDIGEN PHARMA — together account for 100% of total trade value on this route. The average shipment value of $14.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, INVOICE RAISED TO is the largest importer with 2 shipments worth $28.5K USD — representing 100% of all ibrutinib imports from India on this route.